Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Neurobiol Dis ; 97(Pt B): 127-138, 2017 01.
Article in English | MEDLINE | ID: mdl-27063668

ABSTRACT

Chronic pain affects more than 20% of the UK population. Neurotrophic factors have been identified as therapeutic targets to improve current treatments of chronic pain. This review article focuses on nerve growth factor (NGF) and interleukin-6 (IL-6) as potential therapeutic targets. In this review we highlight the mechanisms of action and the current progress of targeted therapies in clinical trials.


Subject(s)
Chronic Pain/drug therapy , Chronic Pain/metabolism , Interleukin-6/antagonists & inhibitors , Interleukin-6/metabolism , Nerve Growth Factor/antagonists & inhibitors , Nerve Growth Factor/metabolism , Animals , Humans
2.
FASEB J ; 29(8): 3370-8, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25903105

ABSTRACT

Transcriptional alterations are characteristic of persistent pain states, but the key regulators remain elusive. HDAC4 is a transcriptional corepressor that has been linked to synaptic plasticity and neuronal excitability, mechanisms that may be involved in peripheral and central sensitization. Using a conditional knockout (cKO) strategy in mice, we sought to determine whether the loss of HDAC4 would have implications for sensory neuron transcription and nociception. HDAC4 was found to be largely unnecessary for transcriptional regulation of naïve sensory neurons but was essential for appropriate transcriptional responses after injury, with Calca and Trpv1 expression consistently down-regulated in HDAC4 cKO compared to levels in the littermate controls (0.2-0.44-fold change, n = 4 in 2 separate experiments). This down-regulation corresponded to reduced sensitivity to 100 nM capsaicin in vitro (IC50 = 230 ± 20 nM, 76 ± 4.4% wild-type capsaicin responders vs. 56.9 ± 4.7% HDAC4 cKO responders) and to reduced thermal hypersensitivity in the complete Freund's adjuvant (CFA) model of inflammatory pain (1.3-1.4-fold improvement over wild-type controls; n = 5-12, in 2 separate experiments). These data indicate that HDAC4 is a novel inflammatory pain mediator and may be a good therapeutic target, capable of orchestrating the regulation of multiple downstream effectors.


Subject(s)
Histone Deacetylases/metabolism , Hyperalgesia/metabolism , Hypersensitivity/metabolism , Inflammation/metabolism , Animals , Calcitonin/metabolism , Calcitonin Gene-Related Peptide , Capsaicin/pharmacology , Down-Regulation/drug effects , Freund's Adjuvant/pharmacology , Hyperalgesia/drug therapy , Inflammation/drug therapy , Mice , Mice, Inbred C57BL , Mice, Knockout , Nociception/drug effects , Nociception/physiology , Pain/drug therapy , Pain/metabolism , Protein Precursors/metabolism , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/metabolism , TRPV Cation Channels/metabolism , Transcription, Genetic/drug effects , Transcription, Genetic/physiology
3.
Nat Commun ; 8(1): 1778, 2017 11 24.
Article in English | MEDLINE | ID: mdl-29176651

ABSTRACT

Following peripheral axon injury, dysregulation of non-coding microRNAs (miRs) occurs in dorsal root ganglia (DRG) sensory neurons. Here we show that DRG neuron cell bodies release extracellular vesicles, including exosomes containing miRs, upon activity. We demonstrate that miR-21-5p is released in the exosomal fraction of cultured DRG following capsaicin activation of TRPV1 receptors. Pure sensory neuron-derived exosomes released by capsaicin are readily phagocytosed by macrophages in which an increase in miR-21-5p expression promotes a pro-inflammatory phenotype. After nerve injury in mice, miR-21-5p is upregulated in DRG neurons and both intrathecal delivery of a miR-21-5p antagomir and conditional deletion of miR-21 in sensory neurons reduce neuropathic hypersensitivity as well as the extent of inflammatory macrophage recruitment in the DRG. We suggest that upregulation and release of miR-21 contribute to sensory neuron-macrophage communication after damage to the peripheral nerve.


Subject(s)
Exosomes/metabolism , Ganglia, Spinal/metabolism , Macrophages/immunology , MicroRNAs/metabolism , Neuralgia/metabolism , Sensory Receptor Cells/metabolism , Animals , Axons/metabolism , Exosomes/genetics , Ganglia, Spinal/cytology , Ganglia, Spinal/injuries , Humans , Male , Mice , Mice, Inbred C57BL , MicroRNAs/genetics , Neuralgia/genetics , Neuralgia/immunology , Phagocytosis , TRPV Cation Channels/genetics , TRPV Cation Channels/metabolism
4.
Front Mol Neurosci ; 7: 87, 2014.
Article in English | MEDLINE | ID: mdl-25426020

ABSTRACT

Unbiased "omics" techniques, such as next generation RNA-sequencing, can provide entirely novel insights into biological systems. However, cellular heterogeneity presents a significant barrier to analysis and interpretation of these datasets. The neurons of the dorsal root ganglia (DRG) are an important model for studies of neuronal injury, regeneration and pain. The majority of investigators utilize a dissociated preparation of whole ganglia when studying cellular and molecular function. We demonstrate that the standard methods for producing these preparations gives a 10%-neuronal mixture of cells, with the remainder of cells constituting satellite glia and other non-neuronal cell types. Using a novel application of magnetic purification, we consistently obtain over 95% pure, viable neurons from adult tissue, significantly enriched for small diameter nociceptors expressing the voltage gated ion channel Nav1.8. Using genome-wide RNA-sequencing we compare the currently used (10% neuronal) and pure (95% nociceptor) preparations and find 920 genes enriched. This gives an unprecedented insight into the molecular composition of small nociceptive neurons in the DRG, potentially altering the interpretation of previous studies performed at the tissue level, and indicating a number of novel markers of this widely-studied population of cells. We anticipate that the ease of use, affordability and speed of this technique will see it become widely adopted, delivering a greatly improved capacity to study the roles of nociceptors in health and disease.

SELECTION OF CITATIONS
SEARCH DETAIL